Related Articles
Expression of dihydrodiol dehydrogenase in the resected stage I non-small cell lung cancer
Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma
Testes‑specific protease 50 as an independent risk factor for poor prognosis in patients with non‑small cell lung cancer
Tazarotene‑induced gene 2 is associated with poor survival in non‑small cell lung cancer
Clinical significance of expanded Foxp3+ Helios- regulatory T cells in patients with non-small cell lung cancer